Cargando…
The Association of CSF sTREM2 With Cognitive Decline and Its Dynamic Change in Parkinson's Disease: Analysis of the PPMI Cohort
BACKGROUND: Soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) in cerebrospinal fluid (CSF) is a biomarker of microglial activation and increased in several neurodegenerative diseases. However, the role of sTREM2 in Parkinson's diseases (PDs) remains unclear. This stu...
Autores principales: | Qin, Qixiong, Wan, Hengming, Wang, Danlei, Li, Jingyi, Qu, Yi, Zhao, Jingwei, Li, Jiangting, Xue, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245456/ https://www.ncbi.nlm.nih.gov/pubmed/35783125 http://dx.doi.org/10.3389/fnagi.2022.892493 |
Ejemplares similares
-
Freezing of gait is a risk factor for cognitive decline in Parkinson’s disease
por: Qu, Yi, et al.
Publicado: (2022) -
Effect of Cerebral Microbleeds on Cognitive Function and Quality of Life in Parkinson Disease
por: Qin, Qixiong, et al.
Publicado: (2022) -
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
por: Suárez‐Calvet, Marc, et al.
Publicado: (2018) -
CCL5 promotes LFA-1 expression in Th17 cells and induces LCK and ZAP70 activation in a mouse model of Parkinson’s disease
por: Zhao, Jingwei, et al.
Publicado: (2023) -
Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration
por: Franzmeier, Nicolai, et al.
Publicado: (2020)